Dual mTORC1/2 and HER2 blockade results in antitumor activity in preclinical models of breast cancer resistant to anti-HER2 therapy (Q39381586)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dual mTORC1/2 and HER2 blockade results in antitumor activity in preclinical models of breast cancer resistant to anti-HER2 therapy |
scientific article |
Statements
1 reference
Dual mTORC1/2 and HER2 blockade results in antitumor activity in preclinical models of breast cancer resistant to anti-HER2 therapy (English)
1 reference
1 reference
1 reference
Celina García-García
1 reference
Yasir H Ibrahim
1 reference
Maria Teresa Calvo
1 reference
Marta Guzmán
1 reference
Judit Grueso
1 reference
Claudia Aura
1 reference
José Pérez
1 reference
Katti Jessen
1 reference
Yi Liu
1 reference
Christian Rommel
1 reference
José Baselga
1 reference
Maurizio Scaltriti
1 reference
8 March 2012
1 reference
1 reference
18
1 reference
9
1 reference
2603-2612
1 reference
Identifiers
1 reference
1 reference